Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Maison

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
European Journal of Clinical Pharmacology|September 21, 2012
Relationship between recommended chronic heart failure treatments and mortality over 8 years in real-world conditions: a pharmacoepidemiological studyPatrick Maison, Gaelle Desamericq, François Hemery, et al.
Dementia and Geriatric Cognitive Disorders|February 18, 2006
Cognitive impairment related to apathy in early Huntington's diseaseSophie Baudic, Patrick Maison, Guillaume Dolbeau, et al.
European Journal of Endocrinology|May 15, 2009
D3 GH receptor polymorphism is not associated with IGF1 levels in untreated acromegalyPeter Kamenicky, Christine Dos Santos, Consuelo Espinosa, et al.
Fundamental & Clinical Pharmacology|February 2, 2006
French adaptation and preliminary validation of a questionnaire to evaluate understanding of informed consent documents in phase I biomedical researchAdeline Paris, Catherine Cornu, Pascal Auquier, et al.
Fundamental & Clinical Pharmacology|April 8, 2014
The most appropriate primary outcomes to design clinical trials on Huntington's disease: meta-analyses of cohort studies and randomized placebo-controlled trialsLinda Salem, Nadine Saleh, Katia Youssov, et al.
Frontiers in Pharmacology|May 17, 2021
Collaboration Between Health-Care Professionals, Patients, and National Competent Authorities Is Crucial for Prevention of Health Risks Linked to the Inappropriate Use of Drugs: A Position Paper of the ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)Stéphane Vignot, Pascale Daynes, Trystan Bacon, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 15, 2013
The unified Huntington's Disease Rating Scale for advanced patients: validation and follow-up studyKatia Youssov, Guillaume Dolbeau, Patrick Maison, et al.
Pharmacy Practice|July 5, 2021
Patterns of medication errors involving pediatric population reported to the French Medication Error GuichetChristine Azar, Delphine Allué, Marie B Valnet-Rabier, et al.
European Journal of Clinical Pharmacology|June 9, 2005
Utilisation of medications recommended for chronic heart failure and the relationship with annual hospitalisation duration in patients over 75 years of age. A pharmacoepidemiological studyPatrick Maison, Patrick Cunin, François Hemery, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 30, 2013
Unified Huntington's disease rating scale for advanced patients: validation and follow-up studyKatia Youssov, Guillaume Dolbeau, Patrick Maison, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
European Journal of Clinical Pharmacology|September 21, 2012
Relationship between recommended chronic heart failure treatments and mortality over 8 years in real-world conditions: a pharmacoepidemiological studyPatrick Maison, Gaelle Desamericq, François Hemery, et al.
Dementia and Geriatric Cognitive Disorders|February 18, 2006
Cognitive impairment related to apathy in early Huntington's diseaseSophie Baudic, Patrick Maison, Guillaume Dolbeau, et al.
European Journal of Endocrinology|May 15, 2009
D3 GH receptor polymorphism is not associated with IGF1 levels in untreated acromegalyPeter Kamenicky, Christine Dos Santos, Consuelo Espinosa, et al.
Fundamental & Clinical Pharmacology|February 2, 2006
French adaptation and preliminary validation of a questionnaire to evaluate understanding of informed consent documents in phase I biomedical researchAdeline Paris, Catherine Cornu, Pascal Auquier, et al.
Fundamental & Clinical Pharmacology|April 8, 2014
The most appropriate primary outcomes to design clinical trials on Huntington's disease: meta-analyses of cohort studies and randomized placebo-controlled trialsLinda Salem, Nadine Saleh, Katia Youssov, et al.
Frontiers in Pharmacology|May 17, 2021
Collaboration Between Health-Care Professionals, Patients, and National Competent Authorities Is Crucial for Prevention of Health Risks Linked to the Inappropriate Use of Drugs: A Position Paper of the ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)Stéphane Vignot, Pascale Daynes, Trystan Bacon, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 15, 2013
The unified Huntington's Disease Rating Scale for advanced patients: validation and follow-up studyKatia Youssov, Guillaume Dolbeau, Patrick Maison, et al.
Pharmacy Practice|July 5, 2021
Patterns of medication errors involving pediatric population reported to the French Medication Error GuichetChristine Azar, Delphine Allué, Marie B Valnet-Rabier, et al.
European Journal of Clinical Pharmacology|June 9, 2005
Utilisation of medications recommended for chronic heart failure and the relationship with annual hospitalisation duration in patients over 75 years of age. A pharmacoepidemiological studyPatrick Maison, Patrick Cunin, François Hemery, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 30, 2013
Unified Huntington's disease rating scale for advanced patients: validation and follow-up studyKatia Youssov, Guillaume Dolbeau, Patrick Maison, et al.
Pageof 9